Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A. Charman, Jonathan L. Vennerstrom, Sarah Arbe‐Barnes et al.|Proceedings of the National Academy of Sciences|2011Cited by 379
Design and characterization of a novel prostate-specific membrane antigen-targeted radioligand modified with a fatty acid albumin binder for optimized circulation half-lifeShaomei Zeng, Jun Tang, Yao Zhang et al.|EJNMMI Radiopharmacy and Chemistry|2025Cited by 3